Systemic Administration of Soluble Glycoprotein 130 in Traumatic Brain Injury: Effects on Cognitive Performance and Chemokine Levels

Medicine, Rheumatology and Immunology, Medical Laboratory Science, Neurology, Neurosurgery, Life Sciences, Immunology,
Traumatic Brain Injury   Soluble Glycoprotein 130   Cognitive Performance   Chemokine Levels   Neuroinflammation  

Research Review: Treating Traumatic Brain Injury through Selective Inhibition of IL-6 Pathway Background Traumatic brain injury (TBI) is one of the leading causes of long-term neurological damage and death globally, with no effective disease-modifying treatments currently available. TBI patients often suffer from cognitive, behavioral, and sensory ...